Gilead’s Remdesivir Gets US FDA Approval for Hospitalized COVID-19 Patients
1 sourceUpdated Oct 22, 2020
The U.S. Food and Drug Administration on Thursday approved Gilead Sciences Inc’s antiviral drug remdesivir for treating patients hospitalized with COVID-19, making it the first and only drug approved for the disease in…
Claim check
What each side asserts, disputes — or leaves out entirely.
Where do you land?
Whose framing of this story rings truest to you?
Sponsored
Coverage
Comments
Ask Genius by OpenServe:
Free account · your comment posts right after signup
Sponsored